Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$498M |
| 2 |
Micron Technology
MU
|
+$374M |
| 3 |
Amazon
AMZN
|
+$356M |
| 4 |
Accenture
ACN
|
+$318M |
| 5 |
Advanced Micro Devices
AMD
|
+$301M |
Top Sells
| 1 |
Apple
AAPL
|
+$684M |
| 2 |
Meta Platforms (Facebook)
META
|
+$630M |
| 3 |
Tesla
TSLA
|
+$595M |
| 4 |
Chevron
CVX
|
+$497M |
| 5 |
Shopify
SHOP
|
+$439M |
Sector Composition
| 1 | Healthcare | 19.38% |
| 2 | Technology | 18.55% |
| 3 | Consumer Staples | 10.17% |
| 4 | Consumer Discretionary | 9.68% |
| 5 | Financials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Viridian Therapeutics
VRDN
$1.52B
| $2.08M | ﹤0.01% |
+101,600
| New | +$2.08M |
|
|
HMNF
1977
DELISTED
HMN Financial Inc
HMNF
| $2.08M | ﹤0.01% |
92,725
-18,800
| -17% | -$421K |
|
1978
Tanger
SKT
$3.82B
| $2.08M | ﹤0.01% |
151,715
-294,422
| -66% | -$4.03M |
|
1979
Thryv Holdings
THRY
$533M
| $2.07M | ﹤0.01% |
90,800
+63,900
| +238% | +$1.46M |
|
1980
Gentherm
THRM
$1.08B
| $2.07M | ﹤0.01% |
+41,564
| New | +$2.07M |
|
1981
Glacier Bancorp
GBCI
$5.72B
| $2.06M | ﹤0.01% |
41,892
+5,300
| +14% | +$260K |
|
1982
Nerdy
NRDY
$154M
| $2.06M | ﹤0.01% |
975,297
+664,497
| +214% | +$1.4M |
|
1983
Yext
YEXT
$1.08B
| $2.06M | ﹤0.01% |
461,000
-1,157,400
| -72% | -$5.16M |
|
|
ALEX
1984
Alexander & Baldwin
ALEX
$1.35B
| $2.05M | ﹤0.01% |
123,700
-44,231
| -26% | -$733K |
|
1985
International Money Express
IMXI
$431M
| $2.05M | ﹤0.01% |
89,800
+300
| +0.3% | +$6.84K |
|
1986
Smith & Nephew
SNN
$16.2B
| $2.05M | ﹤0.01% |
88,050
-60,000
| -41% | -$1.39M |
|
1987
Antero Midstream
AM
$8.86B
| $2.04M | ﹤0.01% |
222,670
-51,700
| -19% | -$475K |
|
1988
Personalis
PSNL
$508M
| $2.04M | ﹤0.01% |
688,335
-76,476
| -10% | -$227K |
|
1989
The Bancorp
TBBK
$3.55B
| $2.04M | ﹤0.01% |
93,000
+58,300
| +168% | +$1.28M |
|
1990
Annexon
ANNX
$277M
| $2.04M | ﹤0.01% |
330,200
-29,700
| -8% | -$184K |
|
1991
SPDR S&P Dividend ETF
SDY
$20.3B
| $2.04M | ﹤0.01% |
+18,300
| New | +$2.04M |
|
1992
Equifax
EFX
$32.1B
| $2.04M | ﹤0.01% |
11,895
-260,900
| -96% | -$44.7M |
|
1993
iShares Global Infrastructure ETF
IGF
$8.17B
| $2.04M | ﹤0.01% |
+48,700
| New | +$2.04M |
|
|
PYCR
1994
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $2.03M | ﹤0.01% |
+68,700
| New | +$2.03M |
|
1995
The Joint Corp
JYNT
$153M
| $2.03M | ﹤0.01% |
129,078
+900
| +0.7% | +$14.1K |
|
1996
Avidity Biosciences
RNA
$5.75B
| $2.03M | ﹤0.01% |
124,000
+15,700
| +14% | +$256K |
|
1997
Harte-Hanks
HHS
$27.4M
| $2.02M | ﹤0.01% |
181,274
+129,674
| +251% | +$1.45M |
|
1998
Aldeyra Therapeutics
ALDX
$294M
| $2.02M | ﹤0.01% |
378,300
-135,800
| -26% | -$725K |
|
|
YALA
1999
Yalla Group
YALA
$1.21B
| $2.02M | ﹤0.01% |
622,253
-229,747
| -27% | -$744K |
|
2000
SLM Corp
SLM
$5.86B
| $2.01M | ﹤0.01% |
+143,600
| New | +$2.01M |
|